Page 929 - Clinical Small Animal Internal Medicine
P. 929

84  Canine Influenza Virus  867

                 Canine influenza virus survives in the environment for   shed contagious virus. Dogs will completely recover clin-
  VetBooks.ir  more than 24 hours. Because secondary bacterial and   ically within 2–3 weeks, sometimes, however, with a lin-
                                                                  gering cough. Animals that are generally in good health
               mycoplasma infections can cause complications, antimi-
               crobials may be considered if clinical signs are severe or
                                                                  plications. While most infections will be self‐limiting,
               suggest co‐infection. Antiviral drugs exist for influenza,   and well nourished are expected to recover without com-
               but such treatments have not been approved for use in   mortality is considered to be between 1% and 5%.
               dogs. Information is lacking regarding their efficacy,
               doses or negative side‐effects in dogs.
                 The Nobivac® Canine Influenza H3N8 and H3N2 inacti-    Public Health Implications
               vated bivalent vaccine from Intervet/Merck is labelled as
               effective at reducing disease severity. However, the capac-  With the reported transmissions of influenza from birds
               ity for influenza A viruses to mutate provides the risk of   and other mammals to humans, we should consider CIV
               eventual adaptation and evasion of immunity from admin-  strains a potential public health concern. Influenza
               istered vaccines.                                  viruses are commonly transmitted across species
                                                                  although usually with subclinical infection and without
                                                                  further transmission within the second species. However,
                 Prognosis                                        the CIV strains have not been reported to infect humans,
                                                                  even owners with known infected dogs, and the Centers
               From 60% to 80% of CIV‐infected dogs will present with   for Disease Control does not consider the canine influ-
               clinical illness, but subclinically infected dogs will also   enza viruses to be a human threat.


                 Further Reading


               Crawford PC, Dubovi EJ, Castleman WL, et al.       Song DS, An DJ, Moon HJ, et al. Interspecies transmission
                 Transmission of equine influenza virus to dogs. Science   of the canine influenza H3N2 virus to domestic cats in
                 2005; 310(5747): 482–5.                            South Korea. J Gen Virol 2011; 92(Pt 10): 2350–5.
               He W, Li G, Zhu H, et al. Emergence and adaptation of   Song D, Moon HJ, An DF, et al. A novel reassortant canine
                 H3N2 canine influenza virus from avian influenza virus:   H3N1 influenza virus between pandemic H1N1 and
                 an overlooked role of dogs in interspecies transmission.   canine H3N2 influenza viruses in Korea. J Gen Virol
                 Transbound Emerg Dis 2019; 66(2): 842–51.          2012; 93(Pt 3): 551–4.
               Ramírez‐Martínez LA, Contreras‐Luna M, De la Luz J,   Su S, Wang L, Fu X, et al. Equine influenza A (H3N8) virus
                 et al. Evidence of transmission and risk factors for   infection in cats. Emerg Infect Dis 2014; 20(12): 2096–9.
                 influenza A virus in household dogs and their    Voorhees IEH, Glaser AL, Toohey‐Kurth K, et al. Spread of
                 owners. Influenza Other Respir Viruses 2013; 7(6):   canine influenza A(H3N2) virus, United States. Emerg
                  1292–6.                                           Infect Dis 2017; 23(12): 1950–7.
   924   925   926   927   928   929   930   931   932   933   934